Skip to content

Strength Training for Older Breast Cancer Survivors

Strength Training for Older Breast Cancer Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00591747
Enrollment
106
Registered
2008-01-11
Start date
2005-11-30
Completion date
2011-06-30
Last updated
2015-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasm, Osteoporosis, Postmenopausal

Keywords

randomized clinical trial, elderly, cancer survivor, bone health, body composition, signs and symptoms

Brief summary

Women aged 50 and older are disproportionately affected by breast cancer, not only in terms of new diagnoses, but also in terms of survivorship. Approximately 85% of women who receive a first diagnosis of breast cancer are aged 50 and over, thus older women constitute the largest group of breast cancer survivors. Yet, few studies have focused on evaluating whether physical activity and exercise interventions affect long-term symptoms, physical fitness and function, and body composition of older breast cancer survivors. Due to the combined effects of breast cancer, related treatments and aging it is likely that exercise is even more beneficial for older breast cancer survivors than for younger survivors. Along with the cancer-related symptom of fatigue common to cancer survivors, older survivors face age-related declines in bone and muscle mass, muscle strength, bone health and physical function (gait and balance) that are likely exacerbated by reduced physical activity in survivorship and side effects of adjuvant cancer treatment. All women, regardless of age, are at risk for breast cancer recurrence. Recent epidemiologic evidence suggests a link between exercise and reduced risk of cancer recurrence in breast cancer survivors. Strength training is specifically suited to reverse or slow age-related declines in bone, muscle, strength and function and has shown promise to reduce cancer-related fatigue. However, no controlled trials of strength training in older breast cancer survivors have been conducted.

Interventions

BEHAVIORALResistance Exercise

60 minute sessions 3 times a week of moderate-vigorous lower and upper body free-weight strength training plus impact training (jumps). Two of the three sessions are conducted in a supervised setting at a university fitness facility and the third session is a modified version of the exercise program performed at home. Participants are in the exercise program for 12 months

60 minute session 3 times a week focusing on whole body flexibility (stretching) and relaxation (progressive neuromuscular relaxation, focused breathing) exercises. Exercises are selected to be non-weight bearing and require minimal muscle strength in order to provide a contrast to the intervention arm. Two sessions are conducted in a supervised setting at a university fitness center and the third is a home-based version of the program performed at home.

Sponsors

Susan G. Komen Breast Cancer Foundation
CollaboratorOTHER
OHSU Knight Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with early stage breast cancer at age of 50 or older * Completed adjuvant therapy, radiation +/- chemotherapy but selective estrogen receptor modulators (SERMS), (aromatase inhibitors (AIs) ok) at least 1 year prior to enrollment

Exclusion criteria

* Cognitive difficulties that preclude answering the survey questions, participating in performance testing or giving informed consent * Diagnosed osteoporosis * Current regular participation in planned impact activities or resistance training (more than 2 times a week for 30 minutes at a time) * Medication that contraindicates participation in moderate intensity strength training or previous use of medications known to affect bone metabolism * Movement or neurologic disorder, not including chemo-induced peripheral neuropathy

Design outcomes

Primary

MeasureTime frame
Physical functioning (muscle strength, gait and balance), self-report physical and mental health, and fatigue12 months

Secondary

MeasureTime frame
Body composition (fat mass, muscle mass) and bone mineral density of the lumbar spine and proximal femur12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026